This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tew, K. D. Articles by Hoffman, S. J. Search for Related Content PubMed PubMed Citation Articles by Tew, K. D. Articles by Hoffman, S. J.

Ethacrynic Acid and Piriprost as Enhancers of Cytotoxicity in Drug Resistant and Sensitive Cell Lines¹

Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111

Ethacrynic acid and piriprost (6,9-deepoxy-6,9-(phenylimino)-^6,8-prostaglandin I₁) have been shown to potentiate the cytotoxic activity of chlorambucil in rat and human tumor cell lines. Walker 256 rat breast carcinoma cells (WS), with acquired resistance to nitrogen mustards (WR), and two human colon carcinoma cell lines, HT 29 and BE, were sensitized to chlorambucil when either ethacrynic acid or piriprost was administered at the same time as the alkylating agent. Both as single agents and in combination with chlorambucil, there was inhibition of glutathione S-transferase activity as measured with 1-chloro-2,4-dinitrobenzene as a substrate. A depletion in intracellular glutathione was also evident following ethacrynic acid alone or in combination with chlorambucil. Thus, diuretic plant phenols or prostaglandin analogues may have potential therapeutic utility in combination with alkylating agents.

¹ This work was supported by NIH Grant CA 43830-07 and a Bristol-Myers Foundation institutional grant.

Received 8/ 3/87. Revised 12/ 3/87. Revised 3/ 4/88. Accepted 4/ 6/88.

This article has been cited by other articles:

				R. Wang, C. Li, D. Song, G. Zhao, L. Zhao, and Y. Jing Ethacrynic Acid Butyl-Ester Induces Apoptosis in Leukemia Cells through a Hydrogen Peroxide Mediated Pathway Independent of Glutathione S-Transferase P1-1 Inhibition Cancer Res., August 15, 2007; 67(16): 7856 - 7864. [Abstract] [Full Text] [PDF]

				P. Turella, C. Cerella, G. Filomeni, A. Bullo, F. De Maria, L. Ghibelli, M. R. Ciriolo, M. Cianfriglia, M. Mattei, G. Federici, et al. Proapoptotic Activity of New Glutathione S-Transferase Inhibitors Cancer Res., May 1, 2005; 65(9): 3751 - 3761. [Abstract] [Full Text] [PDF]

				T. Nakajima, T. Takayama, K. Miyanishi, A. Nobuoka, T. Hayashi, T. Abe, J. Kato, K. Sakon, Y. Naniwa, H. Tanabe, et al. Reversal of Multiple Drug Resistance in Cholangiocarcinoma by the Glutathione S-Transferase-{pi}-Specific Inhibitor O1-Hexadecyl-{gamma}-glutamyl-S-benzylcysteinyl-D-phenylglycine Ethylester J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 861 - 869. [Abstract] [Full Text] [PDF]

				M. Fujita and M. Z. Hossain Modulation of Pumpkin Glutathione S-Transferases by Aldehydes and Related Compounds Plant Cell Physiol., May 15, 2003; 44(5): 481 - 490. [Abstract] [Full Text] [PDF]

				K. Zhang, M. Chew, E. B. Yang, K. P. Wong, and P. Mack Modulation of Cisplatin Cytotoxicity and Cisplatin-Induced DNA Cross-Links in HepG2 Cells by Regulation of Glutathione-Related Mechanisms Mol. Pharmacol., April 1, 2001; 59(4): 837 - 843. [Abstract] [Full Text]

				A.-S. Johansson, M. Ridderström, and B. Mannervik The Human Glutathione Transferase P1-1 Specific Inhibitor TER 117 Designed for Overcoming Cytostatic-Drug Resistance Is also a Strong Inhibitor of Glyoxalase I Mol. Pharmacol., March 1, 2000; 57(3): 619 - 624. [Abstract] [Full Text]

				M. L. O'Brien, B. Vulevic, S. Freer, J. Boyd, H. Shen, and K. D. Tew Glutathione Peptidomimetic Drug Modulator of Multidrug Resistance-Associated Protein J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1348 - 1355. [Abstract] [Full Text]